Jonas Rutishauser
About
In The Last Decade
Jonas Rutishauser
17 papers receiving 117 citations
Peers
Comparison fields: 5 of 62
- Pathology and Forensic Medicine 36
- Pulmonary and Respiratory Medicine 29
- Epidemiology 23
- Molecular Biology 21
- Physiology 18
Countries citing papers authored by Jonas Rutishauser
This map shows the geographic impact of Jonas Rutishauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Rutishauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Rutishauser more than expected).
Fields of papers citing papers by Jonas Rutishauser
This network shows the impact of papers produced by Jonas Rutishauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Rutishauser. The network helps show where Jonas Rutishauser may publish in the future.
Co-authorship network of co-authors of Jonas Rutishauser
This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Rutishauser. A scholar is included among the top collaborators of Jonas Rutishauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Rutishauser. Jonas Rutishauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 12 | |
| 8 | 21 | |
| 9 | 5 | |
| 10 | 0 | |
| 11 | 8 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 14 | |
| 15 | 0 | |
| 16 | Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: “REDUCE*”, a non-inferiority multicenter trial. (*Reduction in the Use of Corticosteroids in Exacerbated COPD; ISRCTN19646069) | 1 |
| 17 | 14 | |
| 18 | 3 | |
| 19 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.